NCT06990204View on ClinicalTrials.gov

Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia)

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

June 6, 2025

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
Hypertension
Interventions
DRUG

Azilsartan medoxomil 80 mg tablet

1 tablet of 80 mg of azilsartan medoxomil

DRUG

Edarbi® 80 mg tablets

1 tablet of 80 mg of azilsartan medoxomil.

Trial Locations (1)

614101

LLC Professorskaya klinika, Perm

Sponsors
All Listed Sponsors
lead

Gedeon Richter Plc.

INDUSTRY